Cargando…

Predicting benzodiazepine prescriptions: A proof-of-concept machine learning approach

INTRODUCTION: Benzodiazepines are the most commonly prescribed psychotropic medications, but they may place users at risk of serious adverse effects. Developing a method to predict benzodiazepine prescriptions could assist in prevention efforts. METHODS: The present study applies machine learning me...

Descripción completa

Detalles Bibliográficos
Autores principales: Kinney, Kerry L., Zheng, Yufeng, Morris, Matthew C., Schumacher, Julie A., Bhardwaj, Saurabh B., Rowlett, James K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036348/
https://www.ncbi.nlm.nih.gov/pubmed/36970256
http://dx.doi.org/10.3389/fpsyt.2023.1087879
_version_ 1784911632222126080
author Kinney, Kerry L.
Zheng, Yufeng
Morris, Matthew C.
Schumacher, Julie A.
Bhardwaj, Saurabh B.
Rowlett, James K.
author_facet Kinney, Kerry L.
Zheng, Yufeng
Morris, Matthew C.
Schumacher, Julie A.
Bhardwaj, Saurabh B.
Rowlett, James K.
author_sort Kinney, Kerry L.
collection PubMed
description INTRODUCTION: Benzodiazepines are the most commonly prescribed psychotropic medications, but they may place users at risk of serious adverse effects. Developing a method to predict benzodiazepine prescriptions could assist in prevention efforts. METHODS: The present study applies machine learning methods to de-identified electronic health record data, in order to develop algorithms for predicting benzodiazepine prescription receipt (yes/no) and number of benzodiazepine prescriptions (0, 1, 2+) at a given encounter. Support-vector machine (SVM) and random forest (RF) approaches were applied to outpatient psychiatry, family medicine, and geriatric medicine data from a large academic medical center. The training sample comprised encounters taking place between January 2020 and December 2021 (N = 204,723 encounters); the testing sample comprised data from encounters taking place between January and March 2022 (N = 28,631 encounters). The following empirically-supported features were evaluated: anxiety and sleep disorders (primary anxiety diagnosis, any anxiety diagnosis, primary sleep diagnosis, any sleep diagnosis), demographic characteristics (age, gender, race), medications (opioid prescription, number of opioid prescriptions, antidepressant prescription, antipsychotic prescription), other clinical variables (mood disorder, psychotic disorder, neurocognitive disorder, prescriber specialty), and insurance status (any insurance, type of insurance). We took a step-wise approach to developing a prediction model, wherein Model 1 included only anxiety and sleep diagnoses, and each subsequent model included an additional group of features. RESULTS: For predicting benzodiazepine prescription receipt (yes/no), all models showed good to excellent overall accuracy and area under the receiver operating characteristic curve (AUC) for both SVM (Accuracy = 0.868–0.883; AUC = 0.864–0.924) and RF (Accuracy = 0.860–0.887; AUC = 0.877–0.953). Overall accuracy was also high for predicting number of benzodiazepine prescriptions (0, 1, 2+) for both SVM (Accuracy = 0.861–0.877) and RF (Accuracy = 0.846–0.878). DISCUSSION: Results suggest SVM and RF algorithms can accurately classify individuals who receive a benzodiazepine prescription and can separate patients by the number of benzodiazepine prescriptions received at a given encounter. If replicated, these predictive models could inform system-level interventions to reduce the public health burden of benzodiazepines.
format Online
Article
Text
id pubmed-10036348
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100363482023-03-25 Predicting benzodiazepine prescriptions: A proof-of-concept machine learning approach Kinney, Kerry L. Zheng, Yufeng Morris, Matthew C. Schumacher, Julie A. Bhardwaj, Saurabh B. Rowlett, James K. Front Psychiatry Psychiatry INTRODUCTION: Benzodiazepines are the most commonly prescribed psychotropic medications, but they may place users at risk of serious adverse effects. Developing a method to predict benzodiazepine prescriptions could assist in prevention efforts. METHODS: The present study applies machine learning methods to de-identified electronic health record data, in order to develop algorithms for predicting benzodiazepine prescription receipt (yes/no) and number of benzodiazepine prescriptions (0, 1, 2+) at a given encounter. Support-vector machine (SVM) and random forest (RF) approaches were applied to outpatient psychiatry, family medicine, and geriatric medicine data from a large academic medical center. The training sample comprised encounters taking place between January 2020 and December 2021 (N = 204,723 encounters); the testing sample comprised data from encounters taking place between January and March 2022 (N = 28,631 encounters). The following empirically-supported features were evaluated: anxiety and sleep disorders (primary anxiety diagnosis, any anxiety diagnosis, primary sleep diagnosis, any sleep diagnosis), demographic characteristics (age, gender, race), medications (opioid prescription, number of opioid prescriptions, antidepressant prescription, antipsychotic prescription), other clinical variables (mood disorder, psychotic disorder, neurocognitive disorder, prescriber specialty), and insurance status (any insurance, type of insurance). We took a step-wise approach to developing a prediction model, wherein Model 1 included only anxiety and sleep diagnoses, and each subsequent model included an additional group of features. RESULTS: For predicting benzodiazepine prescription receipt (yes/no), all models showed good to excellent overall accuracy and area under the receiver operating characteristic curve (AUC) for both SVM (Accuracy = 0.868–0.883; AUC = 0.864–0.924) and RF (Accuracy = 0.860–0.887; AUC = 0.877–0.953). Overall accuracy was also high for predicting number of benzodiazepine prescriptions (0, 1, 2+) for both SVM (Accuracy = 0.861–0.877) and RF (Accuracy = 0.846–0.878). DISCUSSION: Results suggest SVM and RF algorithms can accurately classify individuals who receive a benzodiazepine prescription and can separate patients by the number of benzodiazepine prescriptions received at a given encounter. If replicated, these predictive models could inform system-level interventions to reduce the public health burden of benzodiazepines. Frontiers Media S.A. 2023-03-10 /pmc/articles/PMC10036348/ /pubmed/36970256 http://dx.doi.org/10.3389/fpsyt.2023.1087879 Text en Copyright © 2023 Kinney, Zheng, Morris, Schumacher, Bhardwaj and Rowlett. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Kinney, Kerry L.
Zheng, Yufeng
Morris, Matthew C.
Schumacher, Julie A.
Bhardwaj, Saurabh B.
Rowlett, James K.
Predicting benzodiazepine prescriptions: A proof-of-concept machine learning approach
title Predicting benzodiazepine prescriptions: A proof-of-concept machine learning approach
title_full Predicting benzodiazepine prescriptions: A proof-of-concept machine learning approach
title_fullStr Predicting benzodiazepine prescriptions: A proof-of-concept machine learning approach
title_full_unstemmed Predicting benzodiazepine prescriptions: A proof-of-concept machine learning approach
title_short Predicting benzodiazepine prescriptions: A proof-of-concept machine learning approach
title_sort predicting benzodiazepine prescriptions: a proof-of-concept machine learning approach
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036348/
https://www.ncbi.nlm.nih.gov/pubmed/36970256
http://dx.doi.org/10.3389/fpsyt.2023.1087879
work_keys_str_mv AT kinneykerryl predictingbenzodiazepineprescriptionsaproofofconceptmachinelearningapproach
AT zhengyufeng predictingbenzodiazepineprescriptionsaproofofconceptmachinelearningapproach
AT morrismatthewc predictingbenzodiazepineprescriptionsaproofofconceptmachinelearningapproach
AT schumacherjuliea predictingbenzodiazepineprescriptionsaproofofconceptmachinelearningapproach
AT bhardwajsaurabhb predictingbenzodiazepineprescriptionsaproofofconceptmachinelearningapproach
AT rowlettjamesk predictingbenzodiazepineprescriptionsaproofofconceptmachinelearningapproach